B2DG Events - 2006

Topic Speaker Title Company Datesort icon Location
B2DG Is off on a Holiday for Dec. 27 and Jan 3, 2012 ' ' 12/27/2011 - 8:30am Happy New
B2DG Is off on a Holiday for Dec. 20, 27 and Jan 3, 2012 ' ' ' 12/20/2011 - 8:30am Happy
Issues and Challenges Confronting Innovation Gail Maderis President and CEO BayBio 12/13/2011 - 6:00pm Wilson
What Is So Complicated About Medical Customer Support? - Views From Behind the Curtains John Jensen, Ron Bucher and Stacey Williams Consultants Respective Consulting Firms 12/06/2011 - 8:30am Sunnyvale
Curing with Innovation - Stanford's BioDesign Program Jessica Hudak President BioDesign Alumni Group, Stanford University 11/29/2011 - 8:30am Sunnyvale
Thanksgiving Holiday Break- No meeting this week Happy Thanksgiving!! ' 11/22/2011 - 8:00am With
Seeing through blood, a new endocardial visualization and therapy technology Vahid Saadat CEO Voyage Medical 11/15/2011 - 8:30am Sunnyvale
Device Development, The FDA, and the University Michael Harrison, MD Professor of Surgery, Pediatrics, Ob-Gyn and Reproductive Sciences, Emeritus University of California San Francisco 11/08/2011 - 6:00pm Wilson
Wireless Health: Needs, Applications, Challenges, and Devices Marta Gaia Zanchi, PhD Principal Consultant, Founder, and Director of Regulatory Strategy Medinnovo LLC and Vascular Access Technologies, Inc 11/01/2011 - 8:30am Sunnyvale
Sorry- Novel Funding Discussion CANCELLED!!!!! Alternative Discussion By Harry Wachob & Audrey Erbes Harry Wachob & Audrey Erbes Board President and Vice President B2DG 10/25/2011 - 8:30am Sunnyvale
How Human Factors Helps Mitigate Risk, Encourage Adherence and Promote Brand Loyalty Ed Geiselhart Director, Product Development and Planning Insight Product Development, LLC 10/18/2011 - 8:30am Sunnyvale
MD as CEO: Pro or Con Steven R. Deitcher, MD President and Chief Executive Officer Talon Therapeutics 10/11/2011 - 6:00pm Wilson
FTC Loses Lundbeck Appeal: Potential Impact on Life Science Industry Acquisition and Mergers Francis M. Fryscak Partner (Antitrust) Cooley LLP 10/04/2011 - 8:30am Sunnyvale
The Road Less Traveled: Federal Funding Options That You Never Knew Existed Chip Allgrove CEO and Co - Founder Advanced Tech - Ops Consulting, LLC 09/27/2011 - 8:30am Sunnyvale
Empowering Pharmacists as Knowledge Engineers and Collaborators in Delivering Health Care Services Rohan Coelho CEO Rexanto 09/20/2011 - 8:30am Sunnyvale
Pipe Dream to Pipeline Daniel Cher, MD Vice President of Clinical and Regulatory Affairs Chestnut Medical Technologies 09/13/2011 - 6:00pm Wilson
Early Pharmaceutical Sciences Involvement Facilitates Small Molecule Development: Importance of Salt and Polymorph Selection Gail L. Strong Senior Director Patheon Pharmaceutical Development Services 09/06/2011 - 8:30am Sunnyvale
No B2DG Meeting on August 30, 2011. We are taking a Pre-holiday vacation until September 6th No Speaker- Enjoy the Labor Day Week Holiday Break ' 08/30/2011 - 8:30am Sunnyvale
Online Virtual Environments for Healthcare Professionals’ Training Parvati Dev, PhD, President Innovation in Learning, Inc., CliniSpace 08/23/2011 - 8:30am Sunnyvale
US Supreme Court’s Ruling in the Stanford v Roche -- Will It Impact the Licensing of IP from Universities Thomas E. Duley Of Counsel DLA Piper LLP 08/16/2011 - 8:30am Sunnyvale
Formulating Pricing & Reimbursement Strategies in a Challenging Global Environment Christian Schuler Partner Simon-Kucher & Partners LLC 08/09/2011 - 6:00pm Wilson
New Treatment Restores Movement to Persons with Stroke and Spinal Cord Injury Dr. Paul Cordo CTO AMES Technology 08/02/2011 - 8:30am Sunnyvale
Attracting Early Stage Venture Capital Samuel Wu, MD, PhD, Managing Director MedImmune Ventures 07/26/2011 - 8:30am Sunnyvale
Doppler ultrasound: technical background and potential new applications Frank Ingle CEO Instruments for Science & Medicine 07/19/2011 - 8:30am Sunnyvale
Pitfalls of Founding a Life Science Company: Invention, Patenting, Development, and Regulatory Challenges and What we Can be Done in Washington DC to Make Things Better Peter G. Milner, MD, FACC Co-Founder and Executive VP Corporate Development Optivia Biotechnology and Co-founder CV Therapeutics, ARYx Therapeutics and ML Labs. 07/12/2011 - 6:00pm Wilson
No B2DG Meeting on July 5th- Happy 4th of July! Please join us next week with Peter Milner at WSGR -Register at http://goo.gl/a6F9H ' ' 07/05/2011 - 8:30am Where

B2DG Events Search